1. Blood−brain barrier transporters and response to CNS-active drugs

   • Bradley L. Urquhart
   • Richard B. Kim

   Review Article 02 September 2009 Pages: 1063 - 1070

   

2. Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study

   • Xia Sheng
   • Li Wei
   • Thomas M. MacDonald

   Review Article 03 September 2009 Pages: 1071 - 1080

   

3. Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

   • Todd Hulgan
   • John P. Donahue
   • The AIDS Clinical Trials Group Study A5138 Team

   Clinical Trial 25 September 2009 Pages: 1081 - 1088

   

4. Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients

   • Monica Bergqvist
   • Johanna Ulfvarson
   • Eva Andersén Karlsson

   Clinical Trial 02 October 2009 Pages: 1089 - 1096

5. Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients

   • Masako Ohno
   • Akiko Yamamoto
   • Junichi Azuma

   Pharmacogenetics 07 July 2009 Pages: 1097 - 1103

   

6. The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia—an exploratory study

   • Ahmed F. Hawwa
   • Jeff S. Millership
   • James C. McElnay

   Pharmacokinetics and Disposition 28 July 2009 Pages: 1105 - 1112

   

7. Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study

   • Richard Hallinan
   • Séverine Crettol
   • Chin B. Eap

   Pharmacokinetics and Disposition 29 July 2009 Pages: 1113 - 1120

   

8. Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients

   • Anastasia Karafoulidou
   • Elena Suarez
   • John C. Lukas

   Pharmacokinetics and Disposition 30 July 2009 Pages: 1121 - 1130

   

9. Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk

   • Simona Monte
   • Alejandro Macchia
   • Gianni Tognoni

   Pharmacoepidemiology and Prescription 14 July 2009 Pages: 1131 - 1138

   

10. The use of driving impairing medicines: a European survey

    • Silvia Ravera
    • Sylvia A. Hummel
    • Johan J. de Gier

    Pharmacoepidemiology and Prescription Open access 21 July 2009 Pages: 1139 - 1147

11. Successful strategy to improve the specificity of electronic statin–drug interaction alerts

    • Hanna Marita Seidling
    • Caroline Henrike Storch
    • Walter Emil Haefeli

    Pharmacoepidemiology and Prescription 30 July 2009 Pages: 1149 - 1157

    

12. Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?

    • John N. van den Anker
    • Karel Allegaert

    Letter to the Editors Open access 07 July 2009 Pages: 1159 - 1160

13. Prognostic value of the quality indicator “concurrent use of three or more psychotropic drugs” among residents of long-term care facilities: a comment

    • Eva Lesén
    • Max Petzold
    • Anders Carlsten

    Letter to the Editors 10 July 2009 Pages: 1161 - 1161

14. Prognostic value of the quality indicator “concurrent use of three or more psychotropic drugs” among residents of long-term-care facilities

    • J. Simon Bell
    • Heidi T. Taipale
    • Kaisu H. Pitkälä

    Letter to the Editors 14 July 2009 Pages: 1163 - 1164

15. Seretide withdrawal increases airway inflammation in moderate COPD patients

    • Zoe Borrill
    • Kay Roy
    • Dave Singh

    Letter to the Editors 15 July 2009 Pages: 1165 - 1166

    

16. Protopathic bias in observational studies on statin effectiveness

    • Maarit Jaana Korhonen
    • Risto Huupponen
    • Arja Helin-Salmivaara

    Letter to the Editors 22 July 2009 Pages: 1167 - 1168